Chewing Gum in Hemodialysis Patients
Evaluation of the Effect of Xylitol Gum on Thirst, Dry Mouth and Nausea in Patients Undergoing Haemodialysis
1 other identifier
interventional
75
1 country
1
Brief Summary
This study was conducted to evaluate the effect of chewing xylitol gum on thirst, dry mouth and nausea in patients undergoing haemodialysis.Patients undergoing haemodialysis often experience thirst, dry mouth and nausea.This was a prospective, non-randomized experimental study involving a control group. The study was carried out with patients undergoing haemodialysis in a private dialysis centre in the northeast of Turkey between July and December 2018. It was completed with a total of 75 patients assigned to the gum group (n=25), mouth spray group (n=25), and control group (n=25).The patients in the gum group chewed xylitol gum for 10 minutes, five times a day for six weeks. Patients in the mouth spray group used two puffs of mouth spray three times a day. No intervention was made in the control group. Data were collected with the Patient Information Form, Charlson Comorbidity Index, Visual Analogue Scale, Rhodes Index of Nausea, Vomiting and Retching, graduated tube, and pH meter. Data were evaluated with Mann-Whitney U, Pearson Chi-square, Kruskal Wallis and Friedman tests. TREND checklist for non-randomised controlled trials was followed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 22, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2020
CompletedFirst Submitted
Initial submission to the registry
January 24, 2022
CompletedFirst Posted
Study publicly available on registry
February 15, 2022
CompletedFebruary 15, 2022
February 1, 2022
1.2 years
January 24, 2022
February 4, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Effect of chewing xylitol gum on thirst
Thirst were evaluated with "Visual Analog Score". VAS is a 10 cm or 100 mm long measuring instrument on a horizontal line with two different ends. The left end of the line is marked as "no" and the right end as "worst".
6 weeks
Effect of chewing xylitol gum on dry mouth
Dry Mouth were evaluated with "Visual Analog Score". VAS is a 10 cm or 100 mm long measuring instrument on a horizontal line with two different ends. The left end of the line is marked as "no" and the right end as "worst".
6 weeks
Secondary Outcomes (3)
Effect of Xylitol Gum on nausea.
6 weeks
Effect of Xylitol Gum on salivary flow rate.
6 weeks
Effect of Xylitol Gum on oral pH.
6 weeks
Study Arms (2)
The chewing gum group
EXPERIMENTALGum group patients consisted of patients who chewed "Xylitol Granule Filled Dragee Sugar Free Gum/Xylitol Gum/First X-Fresh". It is reported that the use of xylitol five times a day (not less than three times) is appropriate and effective (Xylitol, 2020; Xylitol, 2006; Llop, et al., 2010). Therefore, this group of patients was allowed to chew xylitol gum for 10 minutes, five times a day for six weeks.
The mouth spray group
EXPERIMENTALThe patients in the mouth spray group included those who had been using Oral Spray/Act Dry Mouth Spray regularly as two puffs three times a day at the request of the physician for the last two weeks. This group of patients continued to use the mouth spray at the physician's request.
Interventions
Gum Group: Gum group patients consisted of patients who chewed "Xylitol Granule Filled Dragee Sugar Free Gum/Xylitol Gum/First X-Fresh". It is reported that the use of xylitol five times a day (not less than three times) is appropriate and effective (Xylitol, 2020; Xylitol, 2006; Llop, et al., 2010).
Mouth Spray Group: The patients in the mouth spray group included those who had been using Oral Spray/Act Dry Mouth Spray regularly as two puffs three times a day at the request of the physician for the last two weeks. This group of patients continued to use the mouth spray at the physician's request.
Eligibility Criteria
You may qualify if:
- being 18 years or older,
- being able to speak and understand Turkish,
- being oriented to person, place and time,
- receiving haemodialysis treatment for at least three months,
- experiencing dry mouth, thirst and nausea,
- not having any chewing difficulties,
- not having any dental prosthesis for the gum group,
- using mouth spray for the last two weeks at the request of the physician for the mouth spray group.
You may not qualify if:
- hearing and speech impediment,
- being diagnosed with a psychiatric disease,
- using antiemetic drugs, being diagnosed with Sjögren's syndrome,
- receiving radiotherapy or chemotherapy,
- having a salivary gland infection,
- previous salivary gland surgery,
- sucking on ice cubes, chewing mint/lemon peels, and using mouthwash.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Didem Sarımehmetlead
Study Sites (1)
Karadeniz Techinical University
Trabzon, (554) 326-3222, Turkey (Türkiye)
Related Publications (2)
Almutary H, Bonner A, Douglas C. Symptom burden in chronic kidney disease: a review of recent literature. J Ren Care. 2013 Sep;39(3):140-50. doi: 10.1111/j.1755-6686.2013.12022.x. Epub 2013 Jul 4.
PMID: 23826803BACKGROUNDAkgöz N, Arslan S (2017). Examination of Symptoms in Patients Who are on Hemodialysis Treatment. Journal of Nephrology Nursing, 12(1): 20-28.
RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Didem Sarımehmet, PhD
Karadeniz Techinical University
- PRINCIPAL INVESTIGATOR
Sevilay Hintistan, PhD
Karadeniz Techinical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
January 24, 2022
First Posted
February 15, 2022
Study Start
March 3, 2018
Primary Completion
May 22, 2019
Study Completion
December 12, 2020
Last Updated
February 15, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share